Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (8058)	6/9/1998 12:27:00 AM
From: John Dwyer	Read Replies (1) \| Respond to of 9262

[AXPH] Yes, John, that's the question... what will they do? I really wish I knew the answer. They do have a lot of good technology and as you point out, they are financially sound. Again, a pretty good bet at these levels but I'm still a little uncomfortable. You bring up another company I follow, Aurora Biosciences (ABSC). While this is not the thread to discuss these issues in detail, I would be real hesitant to invest my money here. Their robotic systems for Ultra High-Throughput Screening (UHTS) are definitely a work in progress and they have put together a high-powered consortium (of mainly big pharmas) to help fund the development. There are many technical issues to overcome, particularly with the microfluidics module, and I would be really surprised if they were able to stick to their aggressive development schedule. Any substantial delay may result in the need for additional capital which may not go over too well in the markets. Their fluorescent-based assays for screening are really top- notch. I would expect any near-term value to be derived from collaborations involving screening. I agree that this stock has been beaten but I think it is now trading at a reasonable level for it's progress. If the UHTS systems develop on time and are successful (there will be several competitors on the market by then) they will certainly make money here. Add on their revenues from screening deals and they may be profitable... the big money is further down the road so I'm guessing there is still time to wait and see how these programs develop. I don't think ABSC offers good risk/reward right now... maybe in another year after they deliver the next module for their system. Regarding ENMD, that stock had _no business_ being at $70-80/share and it's return to earth is no surprise. Now, I think you are right to say... "ok, they had some good results, should I buy". I don't follow ENMD, perhaps I should, so I can't say for sure. Have you folks had enough biotech yet??? ;^) John

To: John Metcalf who wrote (8058)	6/9/1998 12:36:00 AM
From: Galirayo	Respond to of 9262

[ TTNP / ENMD ] John, TTNP is moving along .. slow but sure. Slow Sto just Triggered today. OBV accumulation indicator was strong enough to bring the Chaikins Cume Money Flow Up. It's moving toward the Trigger now. May take a few days for it to fire but it should add to the upward mobility of TTNP when it does. Chaikins 21 day will follow the Cume in this instance. Fast Sto is still at 53. Lots of room left here. My Fast Sto can go to 100 and hold a day or 2 there. Still looks good. ENMD ... I may look for it to go to the 50 or 89dma. ... 21.68 and if it falls below this 50dma line? ... next is the 89 near 17.74. These prices may be good entry points. Watch to see if it holds the 50 near 21.68. ABSC .. it's tested the 50 several times. It may try again now. The 50 is near 9.7562. The Dragonfly Doji made the short term MAs cross today. It should be added to your Hot Watch List. Ray